Ever since its early clinical use in the 1960s, levodopa has remained the gold standard of symptomatic efficacy in the drug treatment of Parkinson’s disease (PD). Motor response fluctuations and drug-induced dyskinesias seriously compromise the unparalleled symptomatic efficacy of L-dopa during long-term treatment…
Articles Collection
- This article collection was made possible by Cynapsus.
Footer
Copyright © 1999-2024 John Wiley & Sons, Inc. All Rights Reserved.
